Skip to main content

Day: April 29, 2024

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

LONDON, April 29, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading psychedelic-assisted psychotherapy platform with the largest network of licensed therapists focused on psychedelics in the US, today announced they have entered into a research collaboration agreement to inform the development of a scalable and practical delivery and healthcare provider training model for COMP360 psilocybin treatment, if approved for treatment-resistant depression (TRD). The first phase of the collaboration comprises an in-depth information exchange on the COMP360 psilocybin treatment delivery model. Together, Compass and Journey Clinical will work to better understand the patient...

Continue reading

Parsons Wins Position on $464M U.S. Army Remediation Contract

CHANTILLY, Va., April 29, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a position on an indefinite-delivery, indefinite-quantity (IDIQ) multiple award task order contract (MATOC) by the United States Army Environmental Command (USAEC) for remediation services at sites involving hazardous toxic waste, including perfluoroalkyl and polyfluoroalkyl substances (PFAS). The $464 million ceiling value contract consists of a five-year ordering period and is new work for the company. Under this contract, Parsons will compete for task orders to perform evaluation, investigation, and other remediation services at various U.S. Army installations throughout the country and territories. Activities include PFAS treatment, munitions response, and operational range assessments. “Parsons has...

Continue reading

Sampo Group’s results for January–March 2024 will be published on 7 May 2024

SAMPO PLC                PRESS RELEASE        29 April 2024 at 1:10 pm Sampo Group’s results for January–March 2024 will be published on 7 May 2024 Sampo Group will publish the Interim Statement for January–March 2024 on 7 May between 9:30 am and 10:00 am Finnish time (7:30–8:00 am UK time). The report, Investor Presentation and a video review with Group CFO Knut Arne Alsaker will be available at www.sampo.com/result. Conference call 7 May at 2:30 pm Finnish time (12:30 pm UK time)Tel. +1 786 697 3501, +44 (0) 33 0551 0200, +46 (0) 8 5052 0424, or +358 (0)9 2319 5437. Conference passcode: Sampo Q1 Group CEO Torbjörn Magnusson, Group CFO Knut Arne Alsaker, CEO of If P&C Morten Thorsrud, and Head of IR Sami Taipalus will attend the conference call for investors and analysts. The conference call can also be followed live at www.sampo.com/result....

Continue reading

MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation of a Phase 3 study for the treatment of nontuberculous mycobacterial (NTM) lung disease. “Oral clofazimine has been utilized as a treatment option for patients living with NTM lung disease and we believe that by reducing the dose and administering it directly to the lung we can demonstrate improved dosing, tolerability and safety,” said Michael...

Continue reading

Trump Media Provides Additional Information to DJT Investors Regarding Recalling Shares

SARASOTA, Fla., April 29, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group Corp. (NASDAQ: DJT) (“TMTG” or the “Company”) is highlighting actions DJT shareholders can take to prevent the lending of their shares by brokerage firms for the purpose of short selling. The Company’s shareholder base primarily consists of retail investors who hold their shares through various brokerage firms. Many of these retail shareholders invested in DJT because they support TMTG’s mission to create a free-speech beachhead against Big Tech censorship. TMTG wants to clarify that if shares are currently on loan by brokerage firms to facilitate short selling, shareholders have the option of asking their broker to recall their shares. After recalling their shares, long-term shareholders who believe in the Company’s future can then hold their...

Continue reading

Implementation of capital reduction

Nasdaq CopenhagenLondon Stock Exchange        Euronext DublinOther partners                 Date        29 April 2024 Implementation of capital reduction As advised in the company announcement of 28 February 2024 “Minutes of the annual general meeting held on 28 February 2024”, it was decided at the bank´s annual general meeting to reduce the bank’s share capital by nom. DKK 784,600 by cancellation of 784,600 own shares. The deadline of the statutory notice to the bank’s creditors has expired with no claims being reported, and final registration of the capital reduction has been made with the Danish Business Authority. Following the capital reduction, Ringkjøbing Landbobank A/S’ nominal share capital is DKK 26,706,739 in 26,706,739 shares. The total maximum number of voting rights amount to 26,706,739.Kind regards Ringkjøbing...

Continue reading

Endeavour Publishes Notice of Annual General Meeting

      ENDEAVOUR PUBLISHES NOTICE OF ANNUAL GENERAL MEETING London, 29 April 2024 – Endeavour Mining plc (LSE:EDV, TSX: EDV, OTCQX: EDVMF) (“Endeavour” or the “Group” or the “Company”) announces that it will hold its 2024 Annual General Meeting (“AGM”) on 30 May 2024 at 3 pm (London time) / 10 am (Toronto time). A copy of the Notice of AGM, including the Management Information Circular and Form of Proxy have been posted or otherwise made available to shareholders, and in compliance with UK Listing Rule 9.6.1 submitted to the Financial Conduct Authority and will shortly be available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. In addition, the Notice of AGM including the Management Information Circular will shortly be filed under the Company’s profile at https://www.sedarplus.ca/...

Continue reading

Tryg A/S – capital reduction

  At Tryg’s annual general meeting on 21 March 2024, it was decided to cancel repurchased shares from the Group’s share buy back programmes. The Group’s share capital is reduced by nominal DKK 92,214,355 to nominal DKK 3,081,960,545. The reduction of the share capital was announced by the Danish Business Authority on 22 March 2024. Tryg has not received any objections to the capital reduction. Therefore, the reduction is effective as the Danish Business Authority has registered the capital reduction. After the cancellation of the 18,442,871 repurchased shares, Tryg’s share capital amounts to nominal DKK 3,081,960,545 equivalent to 616.392.109 shares.Attachment16_2024_Tryg__capital_reduction

Continue reading

Iveco Group N.V. to present its 2024 First Quarter Results on 10th May 2024

Turin, 29th April 2024. Iveco Group N.V. (EXM: IVG) confirmed today that its financial results for the First Quarter of 2024 will be presented on Friday, 10th May 2024. A live audio webcast of the conference call will begin at 11:00 am CEST / 10:00 am BST on Friday, 10th May 2024. Details for accessing the webcast are available at the following link: Q1 2024 Iveco Group Webcast The related press release and presentation will be posted on the corporate website at www.ivecogroup.com on Friday, 10th May 2024. For those unable to take part in the live session, a replay will be available in the Investors section of the company website (www.ivecogroup.com) following the conference call. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands...

Continue reading

Aurora Mobile Launches JPush HarmonyOS SDK Fully Compatible with HarmonyOS NEXT

SHENZHEN, China, April 29, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it has officially launched JPush HarmonyOS SDK. The Company worked closely with Huawei to complete the adaptation of JPush HarmonyOS SDK to HarmonyOS NEXT, an iteration of Huawei’s HarmonyOS operating system. The launch of JPush HarmonyOS SDK will provide developers with a more convenient and efficient message push solution to help them succeed in the ever-changing mobile application ecosystem. With the rapid development of HarmonyOS, more and more developers are looking to implement message push in apps running on HarmonyOS. JPush HarmonyOS SDK is designed to meet the needs of developers for cross-device...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.